Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
NCT00036088 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 530
Last updated 2006-07-19
Summary
The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia
Conditions
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-08-31
- Completion
- 2002-07-31
Countries
- United States
- Argentina
- Austria
- Brazil
- Germany
- Ireland
- Mexico
- Peru
- Puerto Rico
- Spain
- United Kingdom
- Venezuela
Study Locations
More Related Trials
-
A Study of Olanzapine in Patients With Schizophrenia
NCT00970281 ·Status: COMPLETED ·Phase: PHASE3
-
A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia
NCT00089869 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study for Patients With Schizophrenia
NCT00520923 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia
NCT00088478 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
NCT00100776 ·Status: COMPLETED ·Phase: PHASE4
-
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
NCT00034580 ·Status: COMPLETED ·Phase: PHASE4
-
Phase IIA Study in Patients With Schizophrenia
NCT00686998 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
NCT00088465 ·Status: COMPLETED ·Phase: PHASE3
-
Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
NCT00485680 ·Status: COMPLETED ·Phase: PHASE3
-
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
NCT00485498 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
NCT00712686 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia
NCT00640510 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term, Open-Label, Study on Schizophrenia
NCT01129674 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Long-Term Study in Schizophrenia
NCT01487083 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Olanzapine in Patients With Acute Agitation
NCT05803642 ·Status: UNKNOWN ·Phase: PHASE3
-
Olanzapine Treatment of Patients With Bipolar I Disorder
NCT00510146 ·Status: COMPLETED ·Phase: PHASE3
-
Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)
NCT02287259 ·Status: COMPLETED ·Phase: PHASE4
-
A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
NCT01389908 ·Status: UNKNOWN ·Phase: NA
-
SB-773812 Administered In Adults With Schizophrenia
NCT00259870 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder
NCT00088036 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed
NCT00618748 ·Status: COMPLETED ·Phase: PHASE3
-
Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder
NCT00050206 ·Status: COMPLETED ·Phase: PHASE4
-
To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
NCT00007774 ·Status: COMPLETED ·Phase: PHASE4
-
Weight Gain Management in Patients With Schizophrenia
NCT00486005 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Adolescents With Schizophrenia or Bipolar Disorder
NCT00982020 ·Status: COMPLETED ·Phase: PHASE4